Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

Fig. 3

Graphs with the percentage change from baseline for each group and mean change difference between the CNIC-polypill strategy and usual care after 16 weeks for LDL-cholesterol (a), systolic blood pressure (b), total cholesterol (c), non-HDL cholesterol (d), HDL-cholesterol (e), triglycerides (f), and diastolic blood pressure (g). DBP diastolic blood pressure; HDL high-density lipoprotein cholesterol; LDL-c low-density lipoprotein cholesterol; SBP systolic blood pressure; TC total cholesterol; TG triglycerides

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us